Mariana Oncology
100 Forge, 6th Floor,
Watertown MA 02472
For Media:
Media@marianaoncology.com
For Investors:
Investors@marianaoncology.com
News & Media
Follow us on our journey as we harness the power of radiopharmaceutical technology to take on cancer’s toughest tumors. This journey has brought us to a new name: We are now Mariana Oncology
Check back here for the latest on Mariana Oncology.
Mariana Oncology to be Acquired by Novartis to Advance Precision Radiopharmaceuticals to Treat Cancer
Acquisition of Mariana Oncology brings together two companies at the forefront of novel radiopharmaceutical development, with a total potential value of up to $1.75 billion Watertown, Mass., May 2, 2024 – Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical innovation to treat people with cancer, today announced it will be…
09/07/23
Mariana Oncology Announces $175 Million Series B Financing
05/09/23
Mariana Oncology Expands Management Team, Appoints Linda Bain Chief Operating Officer and Chief Financial Officer
08/17/22
Mariana Oncology Recognized as a 2022 Prix Galien USA Nominee for Prix Galien Startup
03/08/22
Mariana Oncology Appoints Karen Smith, M.D., Ph.D., as Independent Board Director
02/07/22
Mariana Oncology Expands Radiopharmaceutical Expertise with Appointment of Bernard Lambert, Ph.D. as Chief Technology Officer
02/03/22
Mariana Oncology Appoints Kapil Dhingra, MBBS, to Board of Directors
12/01/21
Mariana Oncology Raises $75 Million Financing to Further its Mission of Transforming Cancer Care with Precision Radiopharmaceuticals